Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - IASO PHARMA INC | d27782.htm |
| EX-3.4 - EX-3.4 - IASO PHARMA INC | d27782_ex3-4.htm |
| EX-4.1 - EX-4.1 - IASO PHARMA INC | d27782_ex4-1.htm |
| EX-3.6 - EX-3.6 - IASO PHARMA INC | d27782_ex3-6.htm |
| EX-10.1 - EX-10.1 - IASO PHARMA INC | d27782_ex10-1.htm |
| EX-10.6 - EX-10.6 - IASO PHARMA INC | d27782_ex10-6.htm |
| EX-10.17 - EX-10.17 - IASO PHARMA INC | d27782_ex10-17.htm |
| EX-23.1 - EX-23.1 - IASO PHARMA INC | d27782exh_23-1.htm |
Exhibit 3.5
FORM OF AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION
OF
IASO PHARMA INC.
(Pursuant to Sections 242 and 245 of the
General Corporation Law of the State of Delaware)
______________________________________________________
IASO PHARMA INC. (the “Corporation”), a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the “DGCL”),
DOES HEREBY CERTIFY:
1.
The name of the Corporation is IASO Pharma Inc.
2.
The date of the filing of the Corporation’s original Certificate of Incorporation with the Secretary of State was October 5, 2006, under the name Pacific Beach Biosciences, Inc.
3.
This Amended and Restated Certificate of Incorporation was approved by the holders of the requisite number of shares of the Corporation in accordance with Section 228 of the DGCL.
4.
This Amended and Restated Certificate of Incorporation has been duly adopted by the Board of Directors and the stockholders of the Corporation in accordance with Sections 242 and 245 of the DGCL.
5.
The text of the Corporation’s Amended and Restated Certificate of Incorporation is set forth in full on Exhibit A attached hereto.
IN WITNESS WHEREOF, this Amended and Restated Certificate of Incorporation has been executed by a duly authorized officer of the Corporation on this ____ day of ________, 2011.
IASO PHARMA INC.
By: |
Name: Matthew A. Wikler Title: President and Chief Executive Officer |
Exhibit A
AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION
OF
IASO PHARMA INC.
______________________________________________________
FIRST: The name of this corporation is IASO Pharma Inc. (the “Corporation”).
SECOND: The address of the registered office of the Corporation in the State of Delaware is 615 South DuPont Highway, Dover, DE 19901, County of Kent, and the name of its registered agent at such address is National Corporate Research, Ltd.
THIRD: The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware (the “DGCL”).
FOURTH: This Corporation is authorized to issue two classes of stock to be designated “Common Stock” and “Preferred Stock.” The total number of shares which the Corporation is authorized to issue is Fifty Five Million (55,000,000) shares, Fifty Million (50,000,000) of which shall be Common Stock, par value $0.001 per share, and Five Million (5,000,000) of which shall be Preferred Stock, par value $0.001 per share.
FIFTH: The Board of Directors is authorized, subject to any limitations prescribed by law, to provide for the issuance of shares of Preferred Stock in series, and to establish from time to time the number of shares to be included in each such series, and to fix the designation, power, preferences, and rights of the shares of each such series and any qualifications, limitations or restrictions thereof. Except as otherwise required by law, holders of Common Stock shall not be entitled to vote on any amendment to this Certificate of Incorporation (including any certificate of designation filed with respect to any series of Preferred Stock) that relates solely to the terms of one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together as a class with the holders of one or more other such series, to vote thereon by law or pursuant to this Certificate of Incorporation (including any certificate of designation filed with respect to any series of Preferred Stock).
SIXTH: A director of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, except for liability (i) for any breach of the director’s duty of loyalty to the Corporation or its stockholders, (ii) for any act or omission not in good faith or which involves intentional misconduct or a knowing violation of law, (iii) under Section 174 of the DGCL or (iv) for any transaction from which the director derived an improper personal benefit. If the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of the Corporation shall be eliminated or limited to the fullest extent permitted by the DGCL, as so amended. Any repeal or modification of this Article SIXTH shall not adversely affect any right or protection of a director of the Corporation with respect to events occurring prior to the time of such repeal or modification.
SEVENTH: The Corporation shall, to the fullest extent permitted by Section 145 of the DGCL, as the same may be amended and supplemented, indemnify any and all persons whom it shall have power to indemnify under said section from and against any and all of the expenses, liabilities or other matters referred to in or covered by said section, and the indemnification provided for herein shall not be deemed exclusive of any other rights to which those indemnified may be entitled under any By-Law, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in their official capacities and as to action in another capacity while holding such offices, and shall continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the heirs, executors and administrators of such person.
EIGHTH: The Corporation reserves the right to amend, alter, change or repeal any provision contained in this Amended and Restated Certificate of Incorporation, and any other provisions authorized by the laws of the State of Delaware at the time in force may be added or inserted, subject to the limitations set forth in this Amended and Restated Certificate of Incorporation and in the manner now or hereafter provided herein by statue, and all rights, preferences and privileges of whatsoever nature conferred upon stockholders, directors or any other persons whomsoever by and pursuant to this Amended and Restated Certificate of Incorporation in its present form or as amended are granted subject to the rights reserved in this Article EIGHTH.
NINTH: The Corporation hereby confers the power to adopt, amend or repeal its By-Laws upon the Board of Directors. Notwithstanding the forgoing, such power shall not divest or limit the power of the stockholders of the Corporation to adopt, amend or repeal the By-Laws of the Corporation.